Spinola SM, Griffiths GE, Bogdan JA, Menegus MA: Characterization of an 18,000 molecular-weight outer membrane protein of Veliparib mouse Haemophilus ducreyi that contains a conserved surface-exposed epitope. Infect Immun 1992, 60:385–391.PubMedCentralPubMed 9. Fortney KR, Young RS, Bauer ME, Katz BP, Hood
AF, Munson RS, Spinola SM: Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection. Infect Immun 2000,68(11):6441–6448.PubMedCentralPubMedCrossRef this website 10. Janowicz DM, Leduc I, Fortney KR, Katz BP, Elkins C, Spinola SM: A DltA mutant of Haemophilus ducreyi is partially attenuated in its ability to cause pustules in human volunteers. Infect Immun 2006,74(2):1394–1397.PubMedCentralPubMedCrossRef 11. Spinola SM, Wild LM, Apicella MA, Gaspari AA, Campagnari AA: Experimental human infection with Haemophilus ducreyi . J Infect Dis 1994, 169:1146–1150.PubMedCrossRef 12. Janowicz DM, Ofner S, Katz BP, Spinola SM: Experimental infection of human volunteers with Haemophilus ducreyi : fifteen years of clinical data
and experience. J Infect Dis 2009, 199:1671–1679.PubMedCentralPubMedCrossRef 13. Bauer ME, Fortney KR, Harrison A, Janowicz DM, Munson RS Jr, Spinola SM: Identification of Haemophilus ducreyi genes expressed find more during human infection. Microbiology 2008,154(Pt 4):1152–1160.PubMedCentralPubMedCrossRef 14. Green BA, Farley JE, Quinn-Dey T, Deich RA, Zlotnick GW: The e (P4) outer membrane protein of Haemophilus influenzae : biologic activity of anti- e serum and cloning and sequencing of the structural gene. Infect Immun 1991,59(9):3191–3198.PubMedCentralPubMed 15. Morton DJ, Smith A, VanWagoner TM, Seale TW, Whitby PW, Stull TL: Lipoprotein e (P4) of Haemophilus Rho influenzae : role in heme utilization and pathogenesis. Microbes Infect 2007,9(8):932–939.PubMedCentralPubMedCrossRef 16. Reidl J, Mekalanos JJ: Lipoprotein e (P4) is essential for hemin uptake by Haemophilus
influenzae . J Exp Med 1996,183(2):621–629.PubMedCrossRef 17. Reidl J, Schlor S, Kraiss A, Schmidt-Brauns J, Kemmer G, Soleva E: NADP and NAD utilization in Haemophilus influenzae . Mol Microbiol 2000,35(6):1573–1581.PubMedCrossRef 18. Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, Green BA: Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine 2004,22(25–26):3449–3456.PubMedCrossRef 19. Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N: A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine 2005,23(10):1294–1300.PubMedCrossRef 20.